RxDoctor Payments Data

Timothy Hume, MD

Family Medicine · Tompkinsville, KYNPI 1619975240

Payments from drug & device makers

$1,085in general payments, 2019–2025

Across 69 payments — averaging $15.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$177
  • AbbVie$127
  • Pfizer$120
  • Novo Nordisk$88
  • Johnson & Johnson$58
  • AstraZeneca$57
  • plus $458 from 17 others

What the payments were for

  • Food & beverage$1,085100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,085 in reported general payments places this provider in the 55th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$4,576
Medicare patients
82
Services billed
209

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin98$125,537
OzempicSemaglutide79$105,037
Trelegy ElliptaFluticasone/Umeclidin/Vilanter97$99,949
EliquisApixaban79$74,786
FarxigaDapagliflozin Propanediol78$70,886
XareltoRivaroxaban46$50,331
TrulicityDulaglutide17$37,087
MounjaroTirzepatide21$36,988
LinzessLinaclotide42$28,437
EntrestoSacubitril/Valsartan18$21,931
Potassium Chloride178$6,442
TrintellixVortioxetine Hydrobromide14$6,377
SymbicortBudesonide/Formoterol Fumarate13$3,328
Colestipol Hcl42$3,283
Arnuity ElliptaFluticasone Furoate11$2,787

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$33$125,53798 claims
Novo NordiskOzempic$88$105,03779 claims
GSKTrelegy Ellipta, Arnuity Ellipta$55$102,735108 claims
PfizerEliquis$120$74,78679 claims
AstraZenecaFarxiga, Symbicort$57$74,21491 claims
Lilly USA, LLCTrulicity, Mounjaro$177$74,07538 claims
Johnson & JohnsonXarelto$58$50,33146 claims
AbbVieLinzess, Synthroid$127$29,24561 claims
NovartisEntresto$29$21,93118 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$52$6,37714 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Tompkinsville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →